CODX is expected to report earnings to rise 36.00% to -34 cents per share on November 07
Q3'24
Est.
$-0.34
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.10
Q4'23
Missed
by $1.00
Q3'23
Beat
by $0.09
The last earnings report on August 08 showed earnings per share of -25 cents, beating the estimate of -34 cents. With 168.51K shares outstanding, the current market capitalization sits at 34.70M.
a developer of molecular diagnostics products and tests that represents a radical new advancement in the understanding of the molecular interactions of DNA